Pacific Edge: Glen Costin

New Zealand cancer diagnostics company Pacific Edge has appointed Glen Costin to the new role of president, Asia Pacific, to lead the buildout of the company's APAC business. Previous to joining Pacific Edge, Costin led his own firm, MDL Asia, assisting with the APAC expansion of small and medium-sized medical, diagnostics, and life science companies. Prior to that, he held senior positions at Abcam, Bio-Rad Laboratories, and Becton Dickinson. Pacific Edge's lead product is the urine-based Cxbladder test, which measures gene expression to detect or rule out the presence of bladder cancer.